Dedicated to Discovery. Committed to Care.

Breast and Ovarian Cancer Risk and Prevention

Contact Information

Schedule an appointment

Breast Cancer Risk and Prevention Clinic
New patients

(617) 632-2178

Follow-up appointments

(617) 632-3428

Familial Ovarian Cancer Clinic
New patients

(617) 632-2178

Follow-up appointments

(617) 632-3669

Research Study Information

For information about our research studies, please call (800) 828-6622 (toll free), or contact our study staff listed below.

Mailing address

Friends of the Dana Farber Cancer Risk and Prevention Clinic
Dana-Farber Cancer Institute
44 Binney Street, Dana 9th floor
Boston, MA 02115

Our Staff

Director

Judy Garber, MD, MPH

Breast Cancer Risk and Prevention Clinic
  • Beth A. Overmoyer, MD, FACP
  • Rochelle G. Scheib, MD
  • Daniel Silver, MD, PhD
Familial Ovarian Cancer Center
  • Daniel Cramer, MD
  • Michael Muto, MD
Genetic counselors
  • Anu Chittenden, MS, CGC
  • Monica Dandipani, MS
  • Claire Healey, MS
  • Meredith Keenan, MS, CGC
  • Shelley R. McCormick, MS, CGC
  • Alexandra S. Perez, MS, CGC
  • Irene Rainville, MS, PhD
  • Katherine Schneider MPH, CGC
Nurse Practitioner

Holly O'Kane, RN, MSN, AOPN

Genetics Research Study Staff
Kathy Corso, MPH

Study Manager
katherine_corso@dfci.harvard.edu
Projects: STRIDE, PROSE
(617) 632-6129

Lisa DiGianni, PhD

Senior Research Scientist
lisa_digianni@dfci.harvard.edu

Elizabeth Root, BS

Health Educator
Elizabeth_Root@dfci.harvard.edu
Project: PACE
(617) 582-8833

Kathryn Stoeckert, MA

Project Manager
kathryn_stoeckert@dfci.harvard.edu
(617) 632-6693

Breast Cancer Prevention Research Staff
Carleen Gentry, MA

Clinical Research Coordinator II
carleen_genrty@dfci.harvard.edu
Projects: SEDE, Lapatinib, RpFNA (CALGB)
(617) 632-5399

Hannah Green, MPH

Program Manager
Project: ROSE, SWIFT, WISE
hannah_green@dfci.harvard.edu
(617) 632-2359

Related Story

FAQ on breast cancer screening with MRI

The American Cancer Society has issued new recommendations related to breast cancer screening with Magnetic Resonance Imaging (MRI) in high risk women. read more